Navigation Links
WuXi PharmaTech Announces Second Quarter 2011 Results
Date:8/10/2011

l costs, the growth in operating expenses was mainly due to the hiring of new senior staff and sales and marketing personnel, RMB appreciation, and building of our biology research capabilities.

Second-quarter 2011 GAAP net income increased 35.6% year over year to $18.7 million due to the 33.7% increase in operating income and higher interest income from short-term investments.

Second-quarter 2011 GAAP diluted earnings per ADS increased 34.2% to 25 cents, mainly due to the 35.6% increase in net income, offset by a slightly higher share count due to exercise of stock options.

Non-GAAP ResultsNon-GAAP financial results excluded the impact of share-based compensation expenses and the amortization of acquired intangible assets and the associated deferred tax impact in both the current-year and the prior-year results, and non-recurring costs relating to the previously proposed combination with Charles River Laboratories in the prior-year results.  

Second-quarter 2011 non-GAAP gross profit increased 14.4% year over year to $40.0 million due to revenue growth in Laboratory Services and both strong revenue growth and gross-margin improvement in Manufacturing Services.  Second-quarter 2011 non-GAAP gross margin decreased year over year to 39.5% from 43.2%.  Gross margin in Manufacturing Services, while lower than that in Laboratory Services, improved year over year due to strong revenue growth and increased capacity utilization in our large-scale manufacturing facilities.  Gross margin in Laboratory Services decreased year over year due to higher labor costs, the negative impact from appreciation of the Chinese RMB relative to the U.S. dollar, and increased depreciation expenses from investments in new capabilities and capacity expansion.

Second-quarter 2011 non-GAAP operating income increased 10.8% year over year to $25.0 million, primarily due to the 14.4% increase in non-GAAP gross profit, partially offset by the
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
2. WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release
3. WuXi PharmaTech Announces First-Quarter 2011 Results
4. WuXi PharmaTech Files 2010 Annual Report on Form 20-F
5. WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release
6. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
7. WuXi PharmaTech Schedules Fourth-Quarter 2010 Earnings Release
8. WuXi PharmaTech Provides Update of 2010 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
9. WuXi PharmaTech Presents 2010 Life Science and Chemistry Awards
10. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
11. WuXi PharmaTech Announces Third-Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 21, 2014 Influenza will affect as ... in the United States as high ... thought to spread is from person to person in respiratory ... a serve way of death, but kills much fewer people ... also done by human fluids including sweat, saliva, blood and ...
(Date:10/22/2014)... Sanomedics International Holdings, Inc. (OTCQB: SIMH) – ... & Data Services, demand for thermometers is expected to ... as demand for more accurate digital thermometers continues.  ... largest market for thermometers, and one of the companies ... Holdings, Inc. Sanomedics International Holdings designs, develops, ...
(Date:10/22/2014)... , Oct. 22, 2014 Provectus Biopharmaceuticals, ... therapies. PV-10, its novel investigational drug for cancer, is ... for systemic side effects. Its oncology focus is on ... has completed phase 2 trials of PV-10 as a ... topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
... NEW YORK, Oct. 24, 2011 ... research report is available in its ... Ingredients (APIs) in the Americas Market ... and Generic Segments and the Pharmaceutical ...
... Reportlinker.com announces that a new market ... Pharmaceutical Key Trends 2011 ... http://www.reportlinker.com/p0487117/Pharmaceutical-Key-Trends-2011-–-Biosimilar-Market-Overview.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ... combined biosimilars market size for the US ...
Cached Medicine Technology:Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape 2Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape 3Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape 4Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape 5Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape 6Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape 7Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape 8Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape 9Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape 10Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape 11Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape 12Pharmaceutical Key Trends 2011 - Biosimilar Market Overview 2Pharmaceutical Key Trends 2011 - Biosimilar Market Overview 3Pharmaceutical Key Trends 2011 - Biosimilar Market Overview 4
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
(Date:10/20/2014)... 2014 The newly updated Worldwide Medical ... thousands of facts, figures and forecasts on the global ... sector forecast categories the Worldwide Medical Market Forecasts ... national views on the worldwide medical market to reveal ... gives you data for 2010-2019, covering each country market ...
(Date:10/20/2014)... Wakefield, MA (PRWEB) October 20, 2014 ... be sponsoring a booth at the American Foundation for ... October 25th. The AFSP is a not-for-profit organization that ... year. Net proceeds from these events are used to ... research, but education and personal relationships as well. ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 T.E.N., ... relationship-marketing firm, announced today that William H. Murray, ... the 2014 ISE® Luminary Leadership Award winner. Presented ... achievements of an outstanding leader and industry practitioner ... contributions in advancing the information security industry. , ...
(Date:10/20/2014)... Los Angeles, CA (PRWEB) October 20, 2014 ... embodies fitness expertise, nutritional coaching, corporate wellness programming, authorship, ... MS, CPT, is excited to announce the release of ... , After many years of coaching thousands of ... pioneering nutrition tracking app that does not require calorie ...
Breaking Medicine News(10 mins):Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3
... the Journal of Hospital Medicine , the risk ... upon general medicine inpatients and those with at least ... factors such as having cancer, chronic diseases such as ... medications, the studies identified other factors which increase the ...
... drugs that target specific molecular mechanisms of cancer have improved ... benefits may come with a cost to the patient,s sex ... the European Society for Medical Oncology (ESMO) in Milan, Italy, ... investigate the impact of cancer therapy on the sexual functioning ...
... Dr. David Nabarro, Assistant Secretary-General at the United Nations and ... Food Security Crisis, will deliver the keynote address at the ... Security on Tuesday, Oct. 19, 5 p.m., at Centre Mont-Royal, ... offer a global perspective on prospects for food and nutrition ...
... HealthDay Reporter , TUESDAY, Oct. 12 (HealthDay News) -- ... just as well as those who receive more, new research ... among U.S. hospitals. The studies are published in the ... Medical Association . In the first study, researchers in ...
... virusrelated virus (XMRV) has been the subject of many ... have created an unclear picture of XMRV,s role in ... November 15 issue of The Journal of Infectious ... possible link between XMRV and prostate cancer but not ...
... a synthetic molecule they designed can block activation of a ... some of those cancer cells to survive chemotherapy. ... cells appear to be protected from the toxic effects of ... protein from protecting the cells, the research suggests. As a ...
Cached Medicine News:Health News:Hospital readmission studies: Influencing factors identified 2Health News:Hospital readmission studies: Influencing factors identified 3Health News:Sexual issues a major concern for cancer patients taking new targeted drugs 2Health News:Coordinator of UN high-level task force to open McGill Food Security Conference 2Health News:Heart Surgery Patients Do Fine With Fewer Blood Transfusions: Study 2Health News:Heart Surgery Patients Do Fine With Fewer Blood Transfusions: Study 3Health News:New studies examine links between XMRV and human disease 2Health News:New studies examine links between XMRV and human disease 3Health News:Blocking an oncogene in liver cancer could be potential therapy option 2Health News:Blocking an oncogene in liver cancer could be potential therapy option 3
... Bard® Dermal Allograft ... of most pelvic floor ... highly resistant to suture ... and serves as a ...
The High Pure Viral RNA Kit is intended for general laboratory use and is designed to purify viral RNA from serum or plasma. Viral RNA is used for RT-PCR analysis directly after elution in nuclease-f...
... The QIAamp Viral RNA Mini ... nucleic acids from cell-free fluid ... acids that can be isolated ... are not limited to, RNA ...
... Kit provides a simple, fast and cost-effective ... cell-free samples. This system utilizes guanidine thiocyanate ... RNase and denature proteins. Purified viral RNA ... Northern and RNase protection assays. This system ...
Medicine Products: